Trial Scout

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)

Study Location

Southtowns Gastroenterology

ClinicalTrials.gov Identifier: NCT03566823
Recruitment Status: Recruiting
First Posted: 6/25/2018 12:00:00 AM
Last Update Posted: 3/5/2019 12:00:00 AM

Study Description

Eligibility Criteria

Additional Contacts

Brief Summary

A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)

Condition or Disease

Intervention/Treatment

Other: Placebo / Subcutaneous injection of placebo matched with SHP647 will be administered using a prefilled syringe.

Phase

Phase 3

Detailed Description

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Go to ClinicalTrials.gov >